Neuzumab 440 mg Injection
  1. Home
  2. Pharma Products
  3. Lupin Ltd
  4. Neuzumab 440 mg Injection

Neuzumab 440 mg Injection

Neuzumab 440 mg Injection contains trastuzumab 440 mg, a monoclonal antibody used as targeted cancer therapy. It is mainly used for HER2-positive breast cancer and certain HER2-positive stomach cancers. The medicine is administered by intravenous infusion under the supervision of a qualified healthcare professional.

BUY NOW

Category

Trastuzumab works by binding to the HER2 protein on cancer cells and blocking signals that promote their growth and survival. It may be used alone or together with other anticancer medicines depending on the cancer type and prescribed treatment protocol. Patients generally require monitoring for infusion-related reactions and heart function because trastuzumab can cause cardiac complications in some patients. The dosage and treatment schedule are individualized by the treating oncologist according to the patient’s condition and response to therapy.

Technical Specification

Specification Details
Active Ingredient Trastuzumab
Strength 440 mg
Dosage Form Lyophilized Powder for Injection
Route of Administration Intravenous Infusion
Pack Size 1 Vial, 20 mL
Manufacturer Lupin Ltd

Product Also Known As

Neuzumab 440 mg Injection, Neuzumab 440mg Injection, Neuzumab 440 mg Vial, Neuzumab 440mg Vial, Trastuzumab 440 mg Injection, Trastuzumab 440mg Injection, Trastuzumab 440 mg Vial